Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differences in Ovarian and Other Cancers Risks by Population and BRCA Mutation Location.

Genes - 8 Jul 2021

Sekine Masayuki, Nishino Koji, Enomoto Takayuki

Abstract excerpt

Hereditary breast and ovarian cancer is caused by a germline mutation in BRCA1 or BRCA2 genes. The frequency of germline BRCA1/2 gene mutation carriers and the ratio of germline BRCA1 to BRCA2 mutations in BRCA-related cancer patients vary depending on the population. Genotype and phenotype correlations have been reported in BRCA mutant families, however, the correlations are rarely used for individual risk...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ethnicity

Share to Genetic Predisposition to Disease

Share to Mutation

Share to Neoplasms

Share to Ovarian Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 34356066
DOI: 10.3390/genes12071050
PMCID: PMC8303997

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differences in Ovarian and Other Cancers Risks by Population and BRCA Mutation Location.PMID 34356066Read ↗

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.Semantic proximity Read ↗

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.Semantic proximity Read ↗

BRCA mutations: Implications of genetic testing in ovarian cancer.Semantic proximity Read ↗

BRCA mutations in the manifestation and treatment of ovarian cancerSemantic proximity Read ↗

Missed therapeutic and prevention opportunities in women with BRCA-mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature.Semantic proximity Read ↗

BRCA-associated ovarian cancer: from molecular genetics to risk management.Semantic proximity Read ↗

[Clinical and familial characterisation of ovarian cancer patients with germline mutations in the BRCA1/2 gene and the current status of prevention in high-risk groups].Semantic proximity Read ↗

The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer PatientsSemantic proximity Read ↗

Genetic testing by cancer site: ovary.Semantic proximity Read ↗

Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients.Semantic proximity Read ↗

Managing hereditary breast cancer risk in women with and without ovarian cancer.Semantic proximity Read ↗

Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.